Skip to main content
. 2022 Aug 19;13:420. doi: 10.1186/s13287-022-03112-7

Table 2.

Undergoing immunosuppressive therapy at enrollment

Patient Therapy
Patient #1 PDN, CsA
Patient #3 PDN, CsA, MMF
Patient #5 CsA
Patient #6 TAC, MMF
Patient #7 PDN, CsA, MMF
Patient #8 TAC
Patient #9 PDN, CsA, MMF
Patient #10 TAC
Patient #11 PDN

PDN prednisone, CsA cyclosporine-A, MMF mycophenolate mofetil, TAC tacrolimus